Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses.
Brempelis KJ, Cowan CM, Kreuser SA, Labadie KP, Prieskorn BM, Lieberman NAP, Ene CI, Moyes KW, Chinn H, DeGolier KR, Matsumoto LR, Daniel SK, Yokoyama JK, Davis AD, Hoglund VJ, Smythe KS, Balcaitis SD, Jensen MC, Ellenbogen RG, Campbell JS, Pierce RH, Holland EC, Pillarisetty VG, Crane CA.
Brempelis KJ, et al. Among authors: kreuser sa.
J Immunother Cancer. 2020 Oct;8(2):e001356. doi: 10.1136/jitc-2020-001356.
J Immunother Cancer. 2020.
PMID: 33115946
Free PMC article.